These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 12679896)
1. Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups. Bennett JE; Kauffman C; Walsh T; de Pauw B; Dismukes W; Galgiani J; Glauser M; Herbrecht R; Lee J; Pappas P; Powers J; Rex J; Verweij P; Viscoli C Clin Infect Dis; 2003 Apr; 36(Suppl 3):S123-7. PubMed ID: 12679896 [TBL] [Abstract][Full Text] [Related]
2. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. Bennett JE; Powers J; Walsh T; Viscoli C; de Pauw B; Dismukes W; Galgiani J; Glauser M; Herbrecht R; Kauffman C; Lee J; Pappas P; Rex J; Verweij P Clin Infect Dis; 2003 Apr; 36(Suppl 3):S117-22. PubMed ID: 12679895 [TBL] [Abstract][Full Text] [Related]
3. Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection. Almyroudis NG; Kontoyiannis DP; Sepkowitz KA; DePauw BE; Walsh TJ; Segal BH Clin Infect Dis; 2006 Dec; 43(11):1449-55. PubMed ID: 17083020 [TBL] [Abstract][Full Text] [Related]
4. Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis. Bennett JE; Powers J; de Pauw B; Dismukes W; Galgiani J; Glauser M; Herbrecht R; Kauffman C; Lee J; Pappas P; Rex J; Verweij P; Viscoli C; Walsh T Clin Infect Dis; 2003 Apr; 36(Suppl 3):S113-6. PubMed ID: 12679894 [TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of new antifungal agents. Kauffman CA Curr Opin Microbiol; 2006 Oct; 9(5):483-8. PubMed ID: 16904366 [TBL] [Abstract][Full Text] [Related]
14. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
15. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791 [TBL] [Abstract][Full Text] [Related]
16. Is there a role for polyenes in treating invasive mycoses? Cornely OA; Vehreschild JJ; Ullmann AJ Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332 [TBL] [Abstract][Full Text] [Related]
17. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448 [TBL] [Abstract][Full Text] [Related]
18. The experience is CLEAR. Chandrasekar P Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():31-5. PubMed ID: 16707248 [TBL] [Abstract][Full Text] [Related]
19. Design of clinical trials of empiric antifungal therapy in patients with persistent febrile neutropenia: considerations and critiques. Sobel JD Pharmacotherapy; 2006 Jun; 26(6 Pt 2):47S-54S. PubMed ID: 16716122 [TBL] [Abstract][Full Text] [Related]
20. Design of efficacy trials of cytokines in combination with antifungal drugs. Kullberg BJ; Oude Lashof AM; Netea MG Clin Infect Dis; 2004 Oct; 39 Suppl 4():S218-23. PubMed ID: 15546121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]